Join the club for FREE to access the whole archive and other member benefits.

Inside Shift Bioscience’s single-gene rejuvenation breakthrough — Exclusive with CEO Daniel Ives

Levity Podcast Episode -Daniel Ives discusses Shift Bioscience’s groundbreaking single-gene approach to rejuvenation

The episode kicks off with an introduction to the innovative work of Shift Bioscience—exploring breakthrough strategies that aim to make people feel and even become younger—and a conversation with the company’s founder and CEO, Daniel Ives. 

Key Points:

The episode offers a glimpse into a future where ageing might be reconceived as an ongoing process of renewal. Daniel Ives shares the scientific rationale behind the breakthrough, the challenges of translating lab research into real-world applications, and the potential paradigm shift in longevity science ushered in by Shift Bioscience’s pioneering efforts.

  • Reinventing Ageing: Daniel Ives outlines the vision of Shift Bioscience, which aims to reverse age-related decline so that every day feels like an upgrade towards youthfulness.
  • Personalized Rejuvenation: The company’s approach focuses on targeted interventions, including a unique single-gene strategy, to improve overall well-being rather than merely treating symptoms.
  • Scientific Evolution: Shift’s research journey has evolved from studying mitochondrial function to leveraging mouse epigenetic clocks, ultimately leading to a breakthrough in longevity science.
  • AI-Powered Discoveries: The use of artificial intelligence in simulating cellular behaviour is highlighted as a key tool in identifying novel rejuvenation interventions.
  • Breakthrough Study: Ives discusses a new, publicly unveiled study that represents the cutting edge of regenerative medicine and the promise of the single-gene rejuvenation approach.
  • Building a Better Future: The conversation reveals how a future reality might look where individuals could wake up progressively healthier and even biologically younger with each passing day.
  • Funding Milestone: A recent $16 million fundraising round was disclosed, marking a significant step to scale the innovative research and potential applications.
  • Bridging Theory and Practice: Emphasis is placed on translating complex molecular biology into tangible, practical interventions that could alter the landscape of ageing.

Visit website: https://www.youtube.com/watch?v=vdOVKZ8Q7kg

See also

LEVITY Podcast

Ageing Science and radical life extension podcast with Peter Ottsjö and Ingemar Patrick Linden

Details last updated 19-Jun-2025

Mentioned in this Resource

Daniel Ives

Founder and CEO of Shift Bioscience Limited

Shift Bioscience

Simulation guided cell rejuvenation to defeat the diseases of aging

Topics mentioned on this page:
Rejuvenation